InsiderPulseNo transactions found.
No financial data available for ORGS.
Company may not file with SEC or CIK is unresolved.
Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio
Orgenesis announces 1-for-10 reverse stock split to regain Nasdaq compliance
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Orgenesis announces $2.3M private placement
Orgenesis to buy stake in Octomera for advancing immuno-oncology portfolio
Orgenesis announces pricing of $1.1M registered direct offering
Orgenesis announces proposed underwritten public offering
Orgenesis Inc. (ORGS) Q4 2022 Earnings Call Transcript
ONCS, ATLX and AMAM among mid-day movers